Contact Details
Tel Number:   +27 71 182 9740   Fax Number:   +27 21 945 1836
Email Address:
Fundisa African Academy of Medicines Development - Specialised in Pharmaceutical workshops in Western Cape, Cape Town


Our Clinical Investigator Certificate (CLIC) Course (CPD accredited), which was held on the 24th to 28th of April 2023 as a face-to-face event was a great success; with over 55 delegates (consisting of Research Investigators, Scientists, members of Health Authorities and Site Support Staff) from across South Africa and Neighboring countries.

The face-to-face meeting also offered the delegates and presenters a great Networking platform for future collaborations and continued learning.

Below is the link to check the content that was covered during the course.

Watch the space for the upcoming Events!
View the Clinical Investigator Certificate (CLIC) Course Content

Fundisa African Academy of Medicines Development

Fundisa African Academy of Medicines Development (FAAMD) is registered as a non-profit Company (Companies and Intellectual Property Commission of South Africa (CIPC), NPC 2014/104973/08; PBO 930054211), and is based in Cape Town, South Africa.

The aim of the Fundisa African Academy of Medicines Development is to provide leadership and capacity building in medicines development and regulation or related sciences by:

The Scientific Advisory Board (SAB) advises on strategic goals, specific teaching and training initiatives, and networking with professional organisations or regulatory agencies. Companies, regulatory agencies and other institutions are invited to join the Academy Support Organisation.
Fundisa African Academy of Medicines Development has been recognized as a Centre of Excellence by the European PharmaTrain Federation which provides an international training network.

Together with the MCC and the National Department of Health, Fundisa African Academy of Medicines Development has organised Workshops on New Developments in Drug Regulation and Pharmacoeconomics.

About Us

Prof Bernd Rosenkranz

Prof Bernd Rosenkranz has a medical degree and is board certified Pharmacologist and Clinical Pharmacologist in Germany and South Africa and Fellow of the Faculty of Pharmaceutical Medicine (FFPM).

He has spent 23 years in industry, as Director of Clinical Pharmacology at Hoechst/Hoechst Marion Roussel in Germany, France and USA, Chief Medical Officer at 3ClinicalResearch in Berlin, Germany, and Vice President Clinical Development at Jerini, Berlin, Germany, where he was responsible for the world-wide clinical programme of icatibant in hereditary angioedema. From 2008 until 2016, he was head of the Division of Clinical Pharmacology, Stellenbosch University (South Africa) where he established the postgraduate programme in Pharmaceutical Medicine / Medicines Development (PharmaTrain Centre of Excellence).

Bernd Rosenkranz is President of the Fundisa African Academy of Medicines Development, and member of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP), the European PharmaTrain Federation, and Honorary Member of the South African Society for Basic and Clinical Pharmacology (SASBCP). He was Chair of the South African Congress of Pharmacology and Toxicology (SACPT 2010), Finance Chair of the 17th World Conference of Basic and Clinical Pharmacology (WCP2014), and is Finance Chair of the 3rd World Conference on Pharmacometrics (WCoP2022, Cape Town). He is convener of a sub-team involved in preparing the COVID-19 Country Report commissioned by the South African government and member of the Scientific Core Team of an initiative on Talent Building within African Regulatory Agencies.

His work has been presented in more than 120 original publications, 18 book chapters, and more than 170 oral or poster presentations. He is Associate Editor of Frontiers in Pharmaceutical Medicine and Outcomes Research.

Bernd Rosenkranz is vice treasurer of the Manenberg Aftercare Centre, Cape Town and airport chaplain in Berlin, Germany.